Metoprolol Succinate
Product Images NDC 0378-4596

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 0378-4596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Metoprolol Succinate Structural Formula (Image 01)

Chemical structure of metoprolol succinate showing the molecular components and the succinate moiety, consistent with the active ingredient in Mylan Pharmaceuticals Inc. product Metoprolol Succinate.*

FDA Label Image

Results For Subgroups In Merit-hf (Image 02)

A forest plot showing relative risk and 95% confidence intervals for subgroups in the MERIT-HF study. It compares outcomes of metoprolol succinate extended-release tablets versus placebo across three categories: total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. Subgroups include geography, NYHA class, ejection fraction, etiology, sex, race, medical history, diabetes status, hypertension status, and heart rate. The plot displays favorability towards metoprolol succinate or placebo for each subgroup.*

FDA Label Image

Metoprolol Succinate Extended-release Tablets, Usp 25 mg Bottle Label (Image 03)

Metoprolol Succinate Extended-Release Tablets, USP, 25 mg by Mylan Pharmaceuticals Inc. The label states 90 tablets per container. It includes caution to verify product dispensed, dosage information, storage instructions, and a barcode. The product is manufactured in India and labeled for prescription use only.*

FDA Label Image

Metoprolol Succinate Extended-release Tablets, Usp 50 mg Bottle Label (Image 04)

Metoprolol Succinate Extended-Release Tablets, USP 50 mg by Mylan Pharmaceuticals Inc. The label shows 90 tablets in a bottle. It includes storage instructions, cautions to keep medication out of reach of children, and a barcode. The label emphasizes 'Verify Product Dispensed' and notes the tablets are for prescription use only.*

FDA Label Image

Metoprolol Succinate Extended-release Tablets, Usp 100 mg Bottle Label (Image 05)

Metoprolol Succinate Extended-Release Tablets, USP 100 mg, from Mylan Pharmaceuticals Inc. The label shows a bottle of 90 film-coated tablets containing 95 mg metoprolol succinate USP equivalent to 100 mg metoprolol tartrate. It includes storage instructions (20° to 25°C), a caution to verify the product dispensed, and mentions manufacturing in India for Mylan Pharmaceuticals in Morgantown, WV. The label also shows an NDC number, barcode, and handling instructions for a child-resistant container.*

FDA Label Image

Metoprolol Succinate Extended-release Tablets, Usp 200 mg Bottle Label (Image 06)

Label for Metoprolol Succinate Extended-Release Tablets, USP 200 mg by Mylan Pharmaceuticals Inc. The label includes NDC 0378-4598-77 and states the package contains 90 tablets. It features dosage information, storage instructions (20° to 25°C), and cautions including keeping medication out of children's reach and verifying product dispensing. The label also indicates the product is manufactured in India and uses a child-resistant closure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.